NEFL and frontotemporal dementia: Neurodegenerative disorders with a typically younger age of onset also demonstrated higher rates of abnormal NfL if a < 65-year cutoff was applied (e.g., FTD, MSA) and plasma NfL was shown to be better at identifying neurodegenerative disorders in younger individuals (<65 years) in comparisons to older individuals (Fig. 4).